Michael Kearney - Core Laboratories Independent Supervisory Director

CLB
 Stock
  

USD 21.97  0.47  2.19%   

  Director
Mr. Michael C. Kearney was Member of the Supervisory Board of Core Laboratories N.V. since June 14, 2004. He is Chairman of the Audit Committee at the Company. In January 2015, Mr. Kearney was elected to the Board of Directors of Fairmount Santrol. Since November 2013, Mr. Kearney has also served on the Supervisory Board of Frank International N.V. Mr. Kearney formerly served as President and Chief Executive Officer of DeepFlex Inc. from September 2009 until June 2013 and had served as the Chief Financial Officer of DeepFlex Inc. from January 2008 until September 2009. Previously, he served as Executive Vice President and Chief Financial Officer of Tesco Corporationrationration, a Canadian based oil service company from October 2004 to January 2007. From 1998 until 2004, Mr. Kearney served as the Chief Financial Officer and Vice President Administration of Hydril Company, a manufacturer of products for petroleum drilling and production
Age: 66  Director Since 2004      
31 20 420 3191  https://www.corelab.com
Kearney has a MS degree in Accountancy and a BBA degree in Finance.

Michael Kearney Latest Insider Activity

Tracking and analyzing the buying and selling activities of Michael Kearney against Core Laboratories stock is an integral part of due diligence when investing in Core Laboratories. Michael Kearney insider activity provides valuable insight into whether Core Laboratories is net buyers or sellers over its current business cycle. Note, Core Laboratories insiders must abide by specific rules, including filing SEC forms every time they buy or sell Core Laboratories'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Core Laboratories Management Efficiency

Core Laboratories has Return on Asset of 0.044 % which means that on every $100 spent on asset, it made $0.044 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.0915 %, implying that it generated $0.0915 on every 100 dollars invested. Core Laboratories management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. The current year Return on Average Assets is expected to grow to 0.0349. The current year Return on Average Equity is expected to grow to 0.14. Core Laboratories Current Assets are projected to decrease significantly based on the last few years of reporting. The past year's Current Assets were at 189.06 Million. The current year Assets Non Current is expected to grow to about 433 M, whereas Total Assets are forecasted to decline to about 571.3 M.
The company has 188.64 M in debt with debt to equity (D/E) ratio of 1.29, which is OK given its current industry classification. Core Laboratories has a current ratio of 2.19, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Core Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, Core Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Core Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Core Laboratories to invest in growth at high rates of return. When we think about Core Laboratories' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing few of many executives

DIRECTOR Since

David NierenbergFlotek Industries
2020
Michael FucciFlotek Industries
2020
L McGuireFlotek Industries
2018
Sonya ReedNow Inc
2021
John ReilandFlotek Industries
N/A
Stephanie HurttDawson Geophysical
2007
Kate RichardFlotek Industries
2018
Ted NorthDawson Geophysical
2015
Michael FrazierNow Inc
2014
Theodore BrownFlotek Industries
2013
Carla HardyFlotek Industries
N/A
Craig CooperDawson Geophysical
2015
Andrea BertoneDmc Global
2019
Mark PloegDawson Geophysical
2015
Peter RoseDmc Global
2016
Michelle AdamsFlotek Industries
2017
Terry BonnoNow Inc
2014
James FerrisDmc Global
2010
Paul HobbyFlotek Industries
2019
David AldousDmc Global
2013
Melvin CooperFlotek Industries
2010
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories is traded on New York Stock Exchange in the United States. Core Laboratories NV (CLB) is traded on New York Stock Exchange in USA and employs 3,600 people. Core Laboratories is listed under Oil & Gas Equipment & Services category by Fama And French industry classification.

Core Laboratories Leadership Team

Elected by the shareholders, the Core Laboratories' board of directors comprises two types of representatives: Core Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Core Laboratories. The board's role is to monitor Core Laboratories' management team and ensure that shareholders' interests are well served. Core Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Core Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
Tahera Khan, Vice President Human Resources
Gwendolyn Schreffler, Senior Vice President, Corporate Development and Investor Relations
Lawrence Bruno, Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating Officer
Monique Eeuwijk, Non-Executive Independent Member of the Supervisory Board
D Ogren, Member of the Supervisory Board
Michael Flecker, Vice President Production Enhancement
Christopher Hill, Chief Financial Officer, Senior Vice President
Alastair Crombie, Vice President Reservoir Description
Mark Elvig, Senior Vice President, Secretary, and General Counsel
Harvey Klingensmith, Non-Executive Independent Member of the Supervisory Board
Michael Straughen, Non-Executive Independent Member of the Supervisory Board
John Ogren, Member of the Supervisory Board
Charles Dunlap, Independent Member of the Board of Supervisory Directors
Monty Davis, COO and Sr. VP
David Hume, Vice President Reservoir Description
Gwendolyn MBA, Sr Relations
J Dumas, Vice President Business Development
Martha Carnes, Presiding Non-Executive Lead Independent Member of the Supervisory Board
Richard Bergmark, CFO, Executive VP and Supervisory Director
Kevin Daniels, Vice President, Chief Accounting Officer
Jacobus Schouten, Managing Director
James Gresham, Senior Vice President Business Development
David Demshur, Independent Chairman of the Board of Supervisory Directors and Chief Executive Officer
Kwaku Temeng, Non-Executive Independent Member of the Supervisory Board
Michael Kearney, Independent Supervisory Director
Peter Boks, Vice President Reservoir Description
Gregory Barnett, Non-Executive Independent Member of the Supervisory Board
Chris Hill, Chief Accounting Officer and VP
Margaret Kempen, Independent Member of the Board of Supervisory Directors
Lucia Geuns, Independent Member of the Board of Supervisory Directors
Jeffrey West, Vice President Production Enhancement
Mark Tattoli, Senior Vice President General Counsel, Secretary
Dumas, Vice President Business Development
Gwendolyn Gresham, Senior Vice President Corporate Development and Investor Relations
Jan Sodderland, Independent Member of the Board of Supervisory Directors

Core Laboratories Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Core Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Core Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Pair Trading with Core Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving together with Core Laboratories

+0.9XPROExpro Group Holdings Upward RallyPairCorr
+0.94APAAPA Corporation Potential GrowthPairCorr
+0.82ARCHArch Resources Normal TradingPairCorr
The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.
The correlation of Core Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
7.47
Market Capitalization
B
Quarterly Revenue Growth YOY
0.068
Return On Assets
0.044
Return On Equity
0.0915
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.